投資有価証券売却益、Impairment LossEL - Chemistry Reportable Segments Member、Net IncomeSE他2件
- 【期間】
| 年度 | 投資有価証券売却益 | Impairment LossEL - Chemistry Reportable Segments Member | Net IncomeSE | 持分法による投資利益 | Share Of Profit Loss Of Investments Accounted For Using Equity MethodIFRS - Engineering Reportable Segment Member |
|---|
| 2009/12 | - | | - | | - | | 219億 | | - | |
| 2010/12 | - | | - | | - | | 577億 | +162.9% | - | |
| 2011/12 | - | | - | | - | | 482億 | -16.4% | - | |
| 2012/12 | - | | - | | - | | 476億 | -1.4% | - | |
| 2013/12 | 446億 | | - | | - | | 531億 | +11.5% | - | |
| 2014/12 | 61.4億 | -86.2% | - | | - | | 621億 | +17.1% | - | |
| 2015/12 | - | | - | | - | | 410億 | -34% | - | |
| 2016/12 | - | | - | | - | | 562億 | +37% | - | |
| 2017/12 | 246億 | +300.3% | - | | - | | 939億 | +67.1% | - | |
| 2018/12 | 303億 | +23.5% | - | | - | | 1057億 | +12.6% | - | |
